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Abstract
Introduction  and  Objective:  Fatigue  can  be  divided  in  perceived  fatigue,  the  feeling  of  exhaus-
tion or  lack  of  energy,  and  performance  fatigue,  the  reduction  in  muscle  force/activation  during
a given  task.  This  meta-analysis  evaluates  the  impact  of  exercise  training  on  fatigue,  compared
with normal  care  in  patients  with  COPD.
Material  and  Methods:  We  searched  randomised  controlled  trials  on  MEDLINE,  EMBASE,
Cochrane Central  Register  of  Controlled  Trials  and  CINAHL  databases  from  their  inception  to
December,  31st  2019  using  the  terms  COPD,  Fatigue,  Fatigability,  Muscle  activation,  Muscle
endurance,  Muscle  Performance,  Voluntary  Activation,  Motoneuron  excitability,  Force  Develop-
ment, Exercise,  AND  Rehabilitation.
Results:  We  evaluated  494  potential  articles.  Sixteen,  all  evaluating  perceived  fatigability,  sat-
isﬁed the  inclusion  criteria  and  were  included.  Twelve  studies  (463  patients)  assessed  fatigue
by the  Chronic  Respiratory  Questionnaire  showing  that  intervention  improved  signiﬁcantly
more than  the  control  group  [SMD  0.708;  95%  CI  0.510,  0.907;  p  <  0.001;  I2 =  34.3%;  p  =  0.116].
Two studies  (68  patients)  using  the  Fatigue  Impact  Scale,  did  not  ﬁnd  any  signiﬁcant  differ-
ences between  groups  [SMD  −0.922;  95%CI  −2.258,  0.413;  p  =  0.176;  I2 =  83.9%;  p  =  0.013].  Two
studies (82  patients)  assessed  perceived  fatigue  by  the  Fatigue  Severity  Scale:  the  interven-
tion improved  signiﬁcantly  more  than  the  control  group  [SMD  −2.282;  95%CI  −2.870,  −1.699;
p <  0.001;  I2 =  64.6%,  p  =  0.093].  No  study  evaluating  performance  fatigue  was  found.Please  cite  this  article  in  press  as:  Paneroni  M,  et  al.  Pulmonol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.004
Abbreviations: SMD, Standardized Mean Difference; CI, Conﬁdence Interval.
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Conclusions:  This  study  provided  low-quality  evidence  of  a  positive  impact  of  different  exercise
training programs  on  perceived  fatigue  in  patients  with  COPD.  Further  studies  are  needed  to
assess the  effects  of  exercise  training  on  fatigue  and  to  test  tailored  programs.
© 2020  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ore  than  half  of  patients  with  chronic  obstructive  pul-
onary  disease  (COPD)  experience  fatigue  which  may  have
 substantial  impact  on  functional  impairment,  physical
ctivity,  health  related  quality  of  life  (HRQL),  mortality,
orbidity,  hospitalization  rate  and  length  of  hospital  stay.1,2
ower  limb  muscles  of  patients  with  COPD  may  show  reduced
ndurance  capacity  and  are  more  prone  to  fatigue,  due
o  disuse,  the  presence  of  limb  muscle  dysfunction,3 and
xercise  vasoconstriction  induced  by  respiratory  muscle
atigue.4,5 These  mechanisms  may  be  responsible  for  the
nset  of  the  symptom  fatigue  during  daily  life.6
It  can  be  divided  into  perceived  fatigue  or  performance
atigue.7 The  ﬁrst  one  is  a  normal  response  to  exercise  or
tress,  a  multidimensional  perception  deﬁned  as  ‘‘the  sub-
ective  feeling  of  tiredness,  exhaustion  or  lack  of  energy,
hich  occurs  on  a  daily  basis’’.7 However,  fatigue  may
lso  occur  during  the  performance  of  a  given  task,  and  is
eﬁned  as  performance  fatigue:  an  objective  and  measur-
ble  domain,  consisting  of  the  reversible  reduction  in  force
enerated  by  the  muscles  during  a  given  task8 such  as  a
onstant  load  exercise.9 It  could  be  distinguished  as  central,
eﬁned  as  a  progressive  reduction  in  the  voluntary  activa-
ion  of  muscle  during  exercise,10 and  peripheral  fatigability,
escribed  by  the  reduction  of  muscle  activation  in  or  distal
o  the  neuromuscular  junction.11
The  reduction  of  fatigue  should  be  one  of  the  aims
f  comprehensive  management  of  patients  with  COPD.12
xercise  training  is  strongly  recommended  in  COPD,  being
ffective  in  reducing  dyspnoea  and  improving  exercise
apacity  and  HRQL.13--15 However,  the  effects  of  exercise
raining  on  fatigue  as  a  primary  aim  in  patients  with  COPD
ave  been  rarely  studied,16,17 and  to  the  best  of  our  knowl-
dge,  there  is  no  systematic  review  of  the  literature  about
he  effectiveness  of  exercise  training  on  fatigue  in  patients
ith  COPD.
Therefore,  the  aim  of  this  systematic  review  and  meta-
nalysis  of  randomized  controlled  trials  (RCTs)  in  patients
ith  COPD,  was  to  evaluate  the  impact  of  interventions
ncluding  exercise  training  on  perceived  and  performance
atigue,  as  compared  to  ordinary  care  or  education  alone.
ethodsPlease  cite  this  article  in  press  as:  Paneroni  M,  et  al.  Pulmonol
his  study  conforms  to  all  Preferred  Reporting  Items
or  Systematic  Reviews  and  Meta-Analyses  guidelines  and
eports  the  required  information  accordingly  (Supplemen-
ary  Checklist,  http://links.lww.com/PHM/A364).ata  sources  and  search  strategies
e  searched  the  following  databases:  MEDLINE,  EMBASE,
ochrane  Central  Register  of  Controlled  Trials,  and  the
umulative  Index  to  Nursing  and  Allied  Health  Litera-
ure,  from  their  inception  to  December,  31st  2019,  with
o  language  restriction.  We  also  reviewed  the  references
f  retrieved  articles  for  additional  studies.  The  search
as  limited  only  to  RCTs  using  the  terms:  COPD,  Fatigue,
atigability,  Muscle  activation,  Muscle  endurance,  Muscle
erformance,  Voluntary  Activation,  Motoneuron  excitability,
orce  Development,  Exercise,  and  Rehabilitation.
atients
e  included  RCTs  involving  patients  with  COPD  according  to
he  Global  Initiative  for  Chronic  Obstructive  Lung  Disease
ecommendations  in  all  stage  of  severity.18 We  excluded
tudies  involving  patients  with  (1)  an  acute  exacerbation
ithin  4  weeks  before  starting  the  intervention;  (2)  major
omorbidities  such  as  chronic  heart  failure,  asthma,  and
leep-related  disorders.
nterventions
e  included  studies  administering  exercise  training  pro-
rams,  with  the  following  characteristics:
 Involving  in-  or  out-patients,  and  home-  or  community-
based  programs;
 Programs  of  2  week  minimum  duration;
 Endurance  and/or  strength  training  of  lower  and/or  upper
limbs;
 Comparing  exercise  training  with  usual  care,  (deﬁned  as
conventional  medical  care  without  any  prescription  of
exercise  training  or  physical  activity)  and/or  education.
utcome  measures
e  included  any  study  assessing:
 Perceived  fatigue:  by  means  of  scales  or  questionnaires
evaluating  subjective  perception  of  fatigue;
 Performance  fatigue:  by  means  of  objective  measures.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.004
evaluating  changes  in  muscle  performance  after  a  fatigu-
ing  task  such  as  muscle  force  or  electromyography  trace
during  a  maximal  voluntary  contraction  (MVC)  or  stimu-
lated  muscle  resting  Twitch.
 IN PRESS+Model
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Table  1  Demographic,  anthropometric  and  clinical  char-
acteristics  of  included  patients.
Clinical  characteristics  No.  studies
(No.
Participants)
Pre-
intervention
Mean  (SD)
Age,  years 15  (596) 64.2  (7.7)
BMI, kg/m2 7  (288)  27.7  (4.7)
FEV1,  %  of  predicted  13  (481)  45.6  (15.2)
FVC,  %  of  predicted  4  (168)  63.6  (15.6)
FEV1/FVC,  %  of  predicted  6  (249)  47.0  (11.1)
RV, %  of  predicted  4  (173)  165.5  (44.1)
PaO2,  mm  Hg  3  (124)  72.5  (8.0)
PaCO2,  mm  Hg 3  (124)  42.8  (5.6)
MIP, %  of  predicted  2  (86)  77.7  (26.7)
MEP,  %  of  predicted  2  (86)  65.9  (19.3)
6MWT,  m  8  (315)  348.3  (77.1)
CRQ fatigue  domain  9  (348)  11.1  (3.4)
FIS units  2  (68)  53.5  (32.3)
FSS units  2  (82)  45.3  (11.1)
CAFS  units  1  (65)  53.8  (17.1)
SGRQ  units  4  (143)  52.6  (14.8)
BMI, Body Mass Index; FEV1, Forced Expiratory Volume in the 1st
second; FVC, Forced Vital Capacity; RV, Residual Volume; MIP,
Maximal Inspiratory Pressure; MEP, Maximal Expiratory Pressure;
CRQ, Chronic Respiratory Questionnaire; FIS, Fatigue Impact
Scale; FSS, Fatigue Severity Scale; CAFS, COPD and Asthma
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Data  collection  and  analysis
Two  investigators  (LB,  MP)  independently  conducted  the
search  of  the  databases,  screening  all  titles  and/or  abstracts
for  the  inclusion  criteria.  Reviewers  then  retrieved  abstracts
and/or  full-text  papers  of  all  potentially  eligible  studies  and
maintained  records  of  all  studies  not  meeting  the  inclusion
criteria.  They  also  provided  the  reasons  for  their  exclusion.
The  investigators  inserted  the  data  of  potentially  eligi-
ble  articles  in  a  Microsoft  Excel  (2013  version,  Microsoft,
Redmond,  WA)  dedicated  database.  Disagreement  between
investigators  about  eligibility  was  resolved  by  discussion
and  consensus.  If  consensus  could  not  be  reached,  a  third
investigator  (MV)  adjudicated.  All  data  were  checked  for
accuracy.  Missing  data  were  requested  by  e-mail  to  the
authors.  An  investigator  (LB)  retrieved  the  full-text  of  the
included  studies  and  inserted  their  data  into  a  dedicated
electronic  database.  Another  investigator  (MP)  indepen-
dently  extracted  data  from  the  same  studies.
The  information  collected  included  the  background
characteristics  of  the  research  reports:  characteristics  of
participants  in  the  study;  number  of  participants  who
dropped  out  or  withdrew  from  the  study;  a  full  descrip-
tion  of  the  exercise  training  programs  (setting,  components,
duration,  and  characteristics);  assessments,  and  associated
results.  If  a  study  reported  multiple  group  comparisons
(e.g.,  exercise  training  plus  free  walking  vs  exercise  training
alone  vs  conventional  care),  treatment  groups  performing
exercise  that  could  be  relevant  to  outcomes  were  combined
into  one  virtual  intervention  group,  and  this  group  was  com-
pared  to  the  group  receiving  conventional  care.
The  investigators  assessed  papers  for  bias  using  the
Cochrane  Collaboration’s  tool  for  assessing  risk  of  bias  in
RCTs.19 Risk  of  bias  was  assessed  according  to  the  follow-
ing  domains:  sequence  generation;  allocation  concealment;
blinding  of  participants;  blinding  of  personnel;  blinding  of
outcome  assessment;  incomplete  outcome  data;  selective
outcome  reporting,  and  other  biases.
Statistical  analysis
Statistical  analysis  was  performed  using  STATA  version  11.2
software  (Stata,  College  Station,  TX).  All  data  were  extrapo-
lated  from  the  corresponding  full-text  studies.  For  outcome,
we  recorded  mean  and  standard  deviation  (SD)  of  variation
from  baseline  to  the  end  of  the  study.  When  SD  was  not  avail-
able,  we  calculated  them  from  standard  errors,  conﬁdence
intervals,  or  t-values  or  contacted  the  trial  authors  by  email
for  clariﬁcation.  We  excluded  studies  with  data  other  than
mean  and  SD.20
The  standardized  mean  difference  (SMD)  was  calculated.
Heterogeneity  of  studies  was  assessed  by  performing  the
Q-test  considering  values  of  P  <  0.01  as  signiﬁcant.  The
ﬁrst  step  of  the  evaluation  was  conducted  by  ﬁxed-effect
models  using  the  Mantel-Haenzel  method.  If  a  signiﬁcant
heterogeneity  among  studies  was  found,  a  random  effect
evaluation  by  the  Der-Simonian  and  Laird  method  approachPlease  cite  this  article  in  press  as:  Paneroni  M,  et  al.  Pulmonol
was  performed.21 Forest  plots  were  used  to  detect  publica-
tion  bias  for  meta-analysis  evaluation  including  more  than  8
studies.22 For  the  meta-analysis,  only  the  outcome  measures
included  in  at  least  two  studies  were  analysed.
T
t
s
sFatigue Scale; SGRQ, St. George’s Respiratory Questionnaire.
esults
e  identiﬁed  494  potentially  relevant  articles.  Of  these,
05  were  excluded  after  the  abstracts  were  read  and  89
ull-texts  were  analysed  for  inclusion  criteria.  Sixteen  out
f  the  48  studies  evaluating  perceived  fatigue  satisﬁed  the
nclusion  criteria  and  were  included  in  the  meta-analysis23--38
Fig.  1).  No  study  out  of  the  other  41  evaluating  changes  in
erformance  fatigue  satisﬁed  the  inclusion  criteria.
Table  1  shows  the  baseline  characteristics  of  the  included
ubjects.  They  suffered  from  moderate-to-severe  COPD.
able  2  shows  the  main  characteristics  of  all  interventions
arried  out  in  the  studies  included.
ettings
even  studies24,26,28,32--34,36 were  conducted  mainly  in  an
ut-patient  setting,  six  at  home 25,27,30,31,37,38 and  three
tudies23,29,35 in  both  settings.
chedules
he  total  duration  of  programs  ranged  from  6  to  24  weeks.
here  were  two  to  seven  sessions  per  week.  The  dura-
ion  of  each  session  ranged  from  30  to  90  min  in  eleven.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.004
tudies23--28,30,32,33,35,36 and  lasted  two  and  a  half  hours  in  one
tudy.34 Four  studies29,31,37,38 did  not  report  any  duration.
Please
 cite
 this
 article
 in
 press
 as:
 Paneroni
 M
,
 et
 al.
 Pulm
onol.
 2020.
 https://doi.org/10.1016/j.pulm
oe.2020.02.004
A
RTICLE IN PRESS
+M
odel
PU
LM
O
E-1446;
 
N
o.
 of
 Pages
 10
4
 
M
.
 Paneroni
 et
 al.
Table  2  Characteristics  of  the  interventions.
Reference  Duration,
weeks
Withdrawal/
dropouts
Participants,  n  Intervention
and  Control
Intervention  Details
Wijkstra23 12  2  28  Intervention:  outpatient  (2  days/week)  and
home  based  cycle  ergometer  and  upper  limb
training,  2  times/day  +inspiratory  muscle
training  and  education  session
30  min  of  training;  cycling  at  60%  of  Wmax,
gradually  extended  to  a  maximum  of  75%  of
Wmax
15 Control:  usual  medical  care
Cambach24 12  23  15  Intervention:  outpatient  training,  3  days/week
+ education  session
90  min  of  cycle  ergometer/rowing
machine/stair-walking  training  (twice  a  week)
at 60--75  %  Wmax;  45  min  of  recreational
activities  such  as  swimming/cycling/hockey
(once  a  week)
8 Control:  usual  medical  care
Larson25 16  77  28  Intervention:  cycle  ergometry  training  at
home,  5  days/week  +  Inspiratory  muscle
training
Interval  training  protocol  with  4  work  sets  of  5
min  separated  by  rest  intervals  (2--4  min);
intensity  of  50%  of  peak  work  rate,  evaluated
weekly  with  progressive  increases  as  tolerated
12 Control:  education
Guell26 24  13  24  Intervention:  cycle  ergometer  training,  5  days/
week  +  breathing  exercise  ad  education  session
30-min  of  cycle  ergometer  at  50%  of  the
maximal  load  (Wmax);  load  increased  in
increments  of  10  W  provided  according  to
symptoms
23 Control:  usual  medical  care
Hernandez27 12  23  20  Intervention:  home-based  walking  training,  6
days/week
1 hour  of  walking  raining  at  70%  of  the
maximum  speed  attained  in  the  SWT
17 Control:  usual  medical  care
Man28 8  8  18  Intervention:  aerobic  and  strength  training,  2
days/week  +  education  session
1  hour  walking/cycling  and  strength  training
for the  upper  and  lower  limb
16 Control:  usual  medical  care
O’Shea29 12  10  20  Intervention:  resistance  exercise,  3  days/week
(1 at  hospital,  2  at  home)
6  resistance  exercises  against  elastic  bands  of
increasing  resistance;  3  sets  of  8  to  12
repetition  maximum
24 Control:  usual  medical  care
Moore30 6  7  10  Intervention:  video  exercise  at  home,  4
days/week  +  education  session
30  min  of  upper  and  lower  limb  strengthening
and  aerobic  exercise
10 Control:  usual  medical  care
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Table  2  (Continued)
Reference Duration,
weeks
Withdrawal/
dropouts
Participants,  n Intervention
and  Control
Intervention  Details
Ghanem31 8  0  25  Intervention:  home-based  endurance  and
strength  training,  7  days/week  +  breathing
exercise
Walking/cycling  training  +  6--10  upper-body
and  lower-body  strength  exercises  with
14 Control:  usual  medical  care
McNamara32 8  8  30  Intervention:  water-based  and  land-based
exercise,  3  days/week
60  min  of  exercise  at  intensity  rating  of  3--5  on
modiﬁed  Borg  scale  for  dyspnea  and  perceived
15 Control:  usual  medical  care
Roman33 12  21  36  Intervention:  Low  intensity  peripheral  muscle
training  and  breathing  exercises,  3/week  +
education  program
15  minutes  breathing  exercises  and  45  minutes
of abdominal  and  upper  and  lower  limb
exercises
14 Control:  usual  medical  care
Wadell34 8  7  17  Intervention:  graduated  exercise  training  for
upper  and  lower  limbs,  3  days/week  +
education  session
2.5  hours  of  graduated  walking/cycle
ergometer  training,  arm  ergometer  and
strength  exercises  for  upper  and  lower  limbs,
at highest  attainable  work  rate  for  the  longest
tolerable  duration
24 Control:  education
Theander35 12  4  12  Intervention:  multidisciplinary  pulmonary
rehabilitation  programme,  2  days/week  +
home  training  programme
10--15  minutes  of  bicycle  training  +  strength
exercise
14 Control:  usual  medical  care
Duruturk36 6  5  29  Intervention:  all-body  callisthenic  exercise  and
cycle ergometer  training,  3  days/week  +
education  session
20/45  min  of  exercise  and  20--30  min  of
continuous  cycling  at  50--70%  of  VO2max;
intensity  adjusted  to  maintain  a  perceived
difﬁculty  level  of  4--7  on  the  Modiﬁed  Borg
Scale
13 Control:  education  session
Arslan37 8  15  32  Intervention:  individualized  exercise  home
program  +  walking  program,  3  days/week
Walking  outdoors  on  a  ﬂat  surface
33 Control:  usual  medical  care.
Mohammad38 7  0  20  Intervention:  home-based  training  program,  3
days/week+  breathing  exercise  and  education
session
Walking  training
20 Control:  usual  medical  care
ARTICLE IN PRESS+ModelPULMOE-1446; No. of Pages 10
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Figure  2  Forest  plot  of  effect  of  training  on:  fatigue  item  in
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cFigure  1  Flow
nterventions
hirteen  studies  included  exercise  training  of  locomo-
or  muscles:  cycling  in  ﬁve  studies,23,25,26,35,36 walking  in
hree27,37,38 and  a  combination  of  these  in  ﬁve.25,28,31,32,34 In
hree  studies  the  intervention  consisted  only  of  calisthenics
xercises.29,30,33
All  the  studies  included  endurance  training.  The  intensity
anging  from  50%  to  75%  of  either  the  maximum  workload  or
xygen  consumption  (VO2)  reached  during  incremental  tests
n  ﬁve  studies.23--26,36 McNamara  et  al.32 used  the  Borg  scale39
o  set  the  intensity  of  the  exercise  (from  3  to  5  on  modi-
ed  Borg  scale)  and  Hernandez  et  al.27 used  the  70%  of  the
aximum  speed  attained  in  the  Incremental  Shuttle  Walking
est  (ISWT);40 nine  others  studies28--31,33--35,37,38 reported  no
raining  intensity.
In six  studies23,24,26,34,35,36 patients  performed  continu-
us  training  on  a  cycloergometer,  while  only  one25 used  the
nterval  training.
dditional  components  of  exercise  training
n  four  studies26,31,34,38 breathing  exercises  were  admin-
stered  in  addition  to  the  exercise  program  (e.g.:
ursued  lip  breathing  and  diaphragmatic  breathing).  In
leven  studies23--26,28,30,33--36,38 educational  sessions  were  also
dministered.  Inspiratory  muscle  training  was  added  in  two
tudies23,25
utcomes
welve  studies23--34 (463  patients:  271  study  group  and  192
ontrols)  evaluated  perceived  fatigue  by  means  of  the
edicated  domain  of  the  chronic  respiratory  questionnaire
CRQ).41 Only  in  three  studies35,37,38 (18.8%)  was  fatigue  mea-
urement  the  primary  outcome.  Fig.  2-Panel  A  shows  thePlease  cite  this  article  in  press  as:  Paneroni  M,  et  al.  Pulmonol
elated  forest  plot:  the  intervention  improved  signiﬁcantly
ore  than  the  control  group  [SMD  0.708;  95%  CI  0.510,  0.907;
 <  0.001;  I2 = 34.3%;  p  =  0.116].  Figure  1SM  describes  funnel
lot  for  studies  on  fatigue  item  in  CRQ.
e
b
d
oRQ scale  (Panel  A),  Fatigue  Index  Scale  (Panel  B)  and  Fatigue
everity  Scale  (Panel  C).
Two  studies35,36 (68  patients:  41  study  group  and  27
ontrols)  used  the  Fatigue  Impact  Scale  (FIS),  which.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.004
xamines  patients’  perceptions  of  their  limitations  caused
y  fatigue  on  the  cognitive,  physical,  and  psychosocial
omains.42 Fig.  2-Panel  B  describes  the  related  forest  plot:
wing  to  the  high  heterogeneity  in  the  ‘‘ﬁxed  analysis
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model’’  (P  =  0.0001),  a  random  effect  model  was  performed.
No  differences  between  intervention  and  control  group
were  found.  [SMD-0.922;  95%CI  −2.258,  0.413;  p  =  0.176;
I2 =  83.9%;  p  =  0.013].
Fig.  2-Panel  C  describes  the  forest  plot  for  two  studies36,38
(82  patients:  49  study  group  and  33  controls)  assess-
ing  fatigue  by  the  Fatigue  Severity  Scale  (FSS),  a  9-item
scale  assessing  disabling  fatigue.  Each  question  evaluates
patients’  perception  in  the  form  of  7-point  modiﬁed  Likert
Scale.43 The  intervention  group  improved  signiﬁcantly  more
than  the  control  group  [SMD  -2.282;  95%CI  −2.870,  −1.699;
p  <  0.001;  I2 =  64.6%,  p  =  0.093].  Only  one  study37 used  the
COPD  and  Asthma  Fatigue  Scale.44
Risk  of  bias
The  assessment  of  the  risk  of  bias  by  funnel  plots  on  CRQ
revealed  high  variability  in  the  results  of  the  included  stud-
ies.  Table  3  shows  results  of  the  risk  of  bias  assessment.  Half
of  the  studies23,25,27,28,31,33,34,38 did  not  report  any  detail  on
randomization  and  allocation  modalities,  and  there  was  a
high  detection  bias  rate.  Almost  all  studies  included  showed
a  high  risk  of  bias  for  the  blinding  of  participants  and  per-
sonnel.
Discussion
This  systematic  review  investigated  the  current  evidence
of  exercise  training  on  fatigue  in  patients  with  COPD.  The
analysis  of  the  16  RCTs  included  evaluating  the  effects  on
perceived  fatigue23--38 showed  high  heterogeneity  of  study
design,  patient  sampling,  exercise  training  schedules,  and
outcome  measures  assessed.  All  studies  showed  a  high  risk
of  bias.  As  a  whole,  the  studies  showed  low-grade  evidence
of  positive  effect  of  exercise  training  on  perceived  fatigue.
No  study  evaluated  the  effects  on  performance  fatigue.
Fatigue  is  an  important  debilitating  symptom  affecting
all  chronic  respiratory  diseases,  including  COPD.  A  four-
year  observational  study  on  fatigue  in  patients  with  COPD
reported  that  severe  fatigue  doubled  in  patients  with  mild
to  severe  COPD  despite  optimal  care.45 Fatigue  is  a  lead-
ing  cause  of  consultations  with  major  clinical  implications.
Despite  its  well-acknowledged  negative  impact  on  patient’s
life,  fatigue  is  still  a  misunderstood  and  underdiagnosed
symptom  in  COPD.  As  a  consequence,  there  is  currently  no
speciﬁc  intervention  to  treat  all  aspects  of  this  symptom
which  is  quite  often  considered  a  secondary  outcome  in
interventions  aiming  primarily  to  increase  physical  ﬁtness
and/or  HRQL.46
Spruit  et  al.9 have  proposed  a  model  of  fatigue  in  patients
with  COPD.  Moderate  to  severe  fatigue  can  be  the  results  of
systemic,  physical,  psychological  and  behavioural  factors.
Fatigue  can  be  precipitated  by  infectious  COPD  exacerbation
and  its  treatment.  This  model  suggests  that  the  fatigue  of
these  patients  is  not  simply  the  result  of  COPD  and  cannot
be  predicted  by  the  sole  degree  of  airﬂow  obstruction  but
would  be  the  consequence  of  multiple  factors  that  may  actPlease  cite  this  article  in  press  as:  Paneroni  M,  et  al.  Pulmonol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.004
alone  or  in  interaction,  at  rest  and  during/after  exercise.10
Rather  interestingly  in  our  systematic  review,  the  posi-
tive  impact  of  pulmonary  rehabilitation  on  perceived  fatigue
was  found  in  studies  using  the  CRQ  and  the  FSS  but  not  the
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IS.  Antoniu  and  Ungureanu46 identiﬁed  8  multidimensional
cales  which  are  commonly  used  to  assess  fatigue  in  COPD
ut  75%  of  RCTs  included  in  our  analysis  evaluated  fatigue  by
eans  of  the  dedicated  domain  of  the  CRQ.41 Houben-Wilke
nd  colleagues  recently  showed  that  the  item  ‘energy’  of
he  COPD  assessment  test  improves  with  the  greatest  effect
n  size  after  pulmonary  rehabilitation.47 A  commonly  used
ulti-dimensional  scale  to  evaluate  fatigue  is  the  subjective
atigue  subscale  of  the  checklist  individual  strength  (CIS-
atigue)48 and  Peters  and  colleagues  reported  a  signiﬁcant
ean  improvement  in  CIS-Fatigue  score  following  12-week
f  pulmonary  rehabilitation  in  patients  with  COPD.49 The  use
f  different  tools  in  papers  prevents  accurate  comparisons
etween  studies  as  the  scores  produced  by  the  scales  show
oor  to  moderate  correlations  between  them.50
It  should  be  noticed  that  we  analysed  exercise  train-
ng,  just  one  (although  the  main)  component  of  pulmonary
ehabilitation  which  is  a  comprehensive  multidisciplinary
ntervention  including,  but  not  limited  to  it.13 Therefore  the
esults  of  our  systematic  review  should  not  be  generalised
o  pulmonary  rehabilitation  programs.
On  the  subject  of  performance  fatigue,  it  is  rather  inter-
sting  to  note  that,  despite  the  fact  that  there  are  some
bservational  studies  describing  high  prevalence  in  patients
ith  COPD,51 we  were  unable  to  include  any  RCT  of  the
ffects  of  exercise  training  on  this  impairment.
Different  tests  have  been  used  to  evaluate  performance
atigue,  which  depends  on  the  ability  of  the  peripheral  mus-
les  and  the  central  nervous  system  to  meet  the  demands
f  a  prescribed  task.  Both  systems  can  exhibit  abnormal
hanges  in  response  to  exercise  and  contribute  to  increased
erformance  fatigue:52,53 we  can  test  it  by  the  changes  in
timulated  resting  Twitch  for  peripheral  involvement  and
y  MVC  for  the  central  ones.53 Thereafter,  speciﬁc  meth-
ds  to  train  the  muscles  and  reduce  the  central  and/or
eripheral  component  of  performance  fatigue,  such  as  the
aximal  strength  training54 or  neuromuscular  electrical
timulation,55 should  also  be  thoroughly  investigated  in  sub-
ects  with  COPD.
onclusion
his  systematic  review  has  provided  low-quality  evidence  of
 positive  impact  of  different  exercise  training  programmes
n  perceived  fatigue  in  patients  with  COPD.  Further  stud-
es  with  better  standardisation  and  scientiﬁc  validity  are
eeded  to  assess  the  effects  of  exercise  training  on  fatigue
nd  to  test  dedicated  programs.  No  study  of  the  efﬁcacy  of
xercise  training  on  performance  fatigue  was  found.
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